Profiles of illicit drug use during annual key holiday and control periods in Australia: Wastewater analysis in an urban, a semi-rural and a vacation area

Addiction

Volumn 108, Issue 3, 2013, Pages 556-565

  Lai, Foon Yin ^a   Bruno, Raimondo ^b   Hall, Wayne ^c   Gartner, Coral ^c   Ort, Christoph ^a,d   Kirkbride, Paul ^e   Prichard, Jeremy ^b   Thai, Phong K ^a   Carter, Steve ^f   Mueller, Jochen F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^e Forensic and Data Centres   (Australia)

^f QUEENSLAND HEALTH   (Australia)

Author keywords

Australia; Cannabis; Cocaine; Drug epidemiology; Ecstasy; LC MSMS; Methamphetamine; Queensland

Indexed keywords

STREET DRUG; WASTE WATER; WATER POLLUTANT;

ADDICTION; ARTICLE; AUSTRALIA; CHEMISTRY; HEALTH; HUMAN; LEISURE; METHODOLOGY; STATISTICS; SUBSTANCE ABUSE; WASTE WATER; WATER POLLUTANT; ANALYSIS; PROCEDURES; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

HOLIDAYS; HUMANS; QUEENSLAND; RURAL HEALTH; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; URBAN HEALTH; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84873995635     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12006     Document Type: Article

References (52)

1. Collins D.J., Lapsley H.M. The costs of tobacco, alcohol and illicit drug abuse to Australian society in 2004/05. National Drug Strategy Monograph Commonwealth Department of Health and Ageing, Canberra: 2008; Chapter 5, Estimation of drug-attributable crime costs, p. 41-47. Available at: http://www.health.gov.au/internet/drugstrategy/publishing.nsf/Content/34F55AF632F67B70CA2573F60005D42B/$File/mono64.pdf (accessed 1 November; archived by WebCite® at http://www.webcitation.org/6CEl53VnY).
2. Australian Institute of Health and Welfare (AIHW). 2010 National Drug Strategy Household Survey report. Drug statistics series no 25, Cat no PHE 145, Canberra: AIHW. 2011.
3. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health (NSDUH): Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011. Available at http://www.samhsa.gov/data/nsduh/2k10nsduh/2k10results.htm accessed 20 January 2012; archived by WebCite® at http://www.webcitation.org/6CGHCGnKA).
4. Flatley J., Smith K. Drug Misuse Declared: Findings from the 2010/11 British Crime Survey England and Wales. 2011. Available at: http://www.homeoffice.gov.uk/publications/science-research-statistics/research-statistics/crime-research/hosb1211/ (accessed 20 January 2012; archived by WebCite® at http://www.webcitation.org/6CGIGdqex).
5. Daughton C. G. Illicit drugs: contaminants in the enviornment and utility in forensic epidemiology. Rev Environ Contam Toxicol 2011; 210: 59-110.
6. Daughton C. G. Illicit drugs in municipal sewage: proposed new nonintrusive tool to heighten public awareness of societal use of illicit-abused drugs and their potential for ecological consequences. Pharmaceuticals and Care Products in the Environment: Scientific and Regulatory Issues American Chemical Society. 2001: 348-64.
7. van Nuijs A. L. N., Castiglioni S., Tarcomnicu I., Postigo C., de Alda M. L., Neels H. etal. Illicit drug consumption estimations derived from wastewater analysis: a critical review. Sci Total Environ 2011; 409: 3564-3577.
8. Zuccato E., Chiabrando C., Castiglioni S., Bagnati R., Fanelli R. Estimating community drug abuse by wastewater analysis. Environ Health Perspect 2008; 116: 1027-1032.
9. Zuccato E., Castiglioni S., Tettamanti M., Olandese R., Bagnati R., Melis M. etal. Changes in illicit drug consumption patterns in 2009 detected by wastewater analysis. Drug Alcohol Depend 2011; 118: 464-469.
10. Adams K., Sandy L., Smith L., Triglone B. Drug use monitoring in Australia: 2007 annual report on drug use among police detainees. Canberra: Australian Institute of Criminology: Research and public policy series no. 93. September 2008.
11. Australian Institute of Criminology (AIC). Fake ecstasy. Canberra: Australian Institute of Criminology: Crime facts info no. 179. September 2008.
12. Vevelstad M., Oiestad E. L., Middelkoop G., Hasvold I., Lilleng P., Delaveris G. J. etal. The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications. Forensic Sci Int 2012; 219: 151-157.
13. Hall W., Prichard J., Kirkbride P., Bruno R., Thai P. K., Gartner C. etal. An analysis of ethical issues in using wastewater analysis to monitor illicit drug use. Addiction 2012; 107: 1767-1773.
14. Irvine R. J., Kostakis C., Felgate P. D., Jaehne E. J., Chen C., White J. M. Population drug use in Australia: a wastewater analysis. Forensic Sci Int 2011; 210: 69-73.
15. Lai F. Y., Ort C., Gartner C., Carter S., Prichard J., Kirkbride P. etal. Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment. Water Res 2011; 45: 4437-4448.
16. Banta-Green C. J., Field J. A., Chiaia A. C., Sudakin D. L., Power L., De Montigny L. The spatial epidemiology of cocaine, methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater. Addiction 2009; 104: 1874-1880.
17. van Nuijs A. L. N., Pecceu B., Theunis L., Dubois N., Charlier C., Jorens P. G. etal. Can cocaine use be evaluated through analysis of wastewater? A nation-wide approach conducted in Belgium. Addiction 2009; 104: 734-741.
18. Thomas K. V., Bijlsma L., Castiglioni S., Covaci A., Emke E., Grabic R. etal. Comparing illicit drug use in 19 European cities through sewage analysis. Sci Total Environ 2012; 432: 432-439.
19. Karolak S., Nefau T., Bailly E., Solgadi A., Levi Y. Estimation of illicit consumption by wastewater analysis in Paris area. Forensic Sci Int 2010; 200: 153-160.
20. Prichard J., Lai F. Y., Kirkbride P., Bruno R., Ort C., Carter S. etal. Measuring drug use patterns in Queensland through wastewater analysis. Australian Institute of Criminology, Trends and Issues in Crime and Criminal Justice. 2012; No. 442: 1-8.
21. Terzic S., Senta I., Ahel M. Illicit drugs in wastewater of the city of Zagreb (Croatia)-estimation of drug abuse in a transition country. Environ Pollut 2010; 158: 2686-2693.
22. Lloyd B. Trends in alcohol and drug related ambulance attendances in Melbourne: 2009/10. Fitzroy, Victoria: Turning Point Alcohol and Drug Centre. 2011.
23. Boyd J., Kuisma M., Randell T. Temporal differences in gamma-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: a retrospective study. Scand J Trauma Resusc Emerg Med 2012; 20: 7.
24. Reid M. J., Langford K. H., Mørland J., Thomas K. V. Quantitative assessment of time dependent drug-use trends by the analysis of drugs and related metabolites in raw sewage. Drug Alcohol Depend 2011; 119: 179-186.
25. Bellis M. A., Hughes K., Bennett A., Thomson R. The role of an international nightlife resort in the proliferation of recreational drugs. Addiction 2003; 98: 1713-1721.
26. Mäkelä P., Martikainen P., Nihtilä E. Temporal variation in deaths related to alcohol intoxication and drinking. Int J Epidemiol 2005; 34: 765-771.
27. Harman C., Reid M., Thomas K. V. In situ calibration of a passive sampling device for selected illicit drugs and their metabolites in wastewater, and subsequent year-long assessment of community drug usage. Environ Sci Technol 2011; 45: 5676-5682.
28. van Nuijs A. L. N., Mougel J. F., Tarcomnicu I., Bervoets L., Blust R., Jorens P. G. etal. A one year investigation of the occurrence of illicit drugs in wastewater from Brussels, Belgium. J Environ Monit 2011; 13: 1008-1016.
29. Fischer B., Rehm J., Brissette S., Brochu S., Bruneau J., El-Guebaly N. etal. Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities. J Urban Health 2005; 82: 250-266.
30. Ort C., Lawrence M. G., Reungoat J., Mueller J. F. Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies. Environ Sci Technol 2010; 44: 6289-6296.
31. Ort C., Lawrence M. G., Rieckermann J., Joss A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. Environ Sci Technol 2010; 44: 6024-6035.
32. van Nuijs A. L. N., Abdellati K., Bervoets L., Blust R., Jorens P. G., Neels H. etal. The stability of illicit drugs and metabolites in wastewater, an important issue for sewage epidemiology? J Hazard Mater 2012; 239-240: 19-23.
33. Chiaia A. C., Banta-Green C., Field J. Eliminating solid phase extraction with large volume injection LC/MSMS: analysis of illicit and legal drugs and human urine indicators in US wastewaters. Environ Sci Technol 2008; 42: 8841-8848.
34. Gheorghe A., van Nuijs A. L. N., Pecceu B., Bervoets L., Jorens P. G., Blust R. etal. Analysis of cocaine and its principal metabolites in waste and surface water using solid-phase extraction and liquid chromatography-ion trap tandem mass spectrometry. Anal Bioanal Chem 2008; 391: 1309-1319.
35. Ambre J., Fischman M., Ruo T. Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J Anal Toxicol 1984; 8: 23-25.
36. Ambre J., Ruo T., Nelson J., Belknap S. Urinary excretion of cocaine, benzoylecgonine and ecgonine methyl ester in humans. J Anal Toxicol 1988; 12: 301-306.
37. Cone E. J., Sampson-Cone A. H., Darwin W. D., Huestis M. A., Oyler J. M. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. J Anal Toxicol 2003; 27: 386-401.
38. Australian Bureau of Statistics (ABS). 3201.0-Population by Age and Sex, Australian States and Territories, Dec 2010. ABS, Canberra. 2010. Available at http://www.abs.gov.au/Ausstats/abs@.nsf/mf/3201.0 (accessed 30 November 2011; archived by WebCite® at http://www.webcitation.org/6CGJSKRUS).
39. Medicare Australia Statistics. Pharmaceutical Benefits Schedule Item Reports. Australian Government. Medicare Australia. 2011. Available at: https://www.medicareaustralia.gov.au/statistics/pbs_item.shtml (accessed 1 October 2011; archived by WebCite® at http://www.webcitation.org/6CGIw6fv3).
40. Australian Crime Commission (ACC). Illicit Drug Data Report 2009-10. Canberra: ACC, 2011. Available at: http://www.crimecommission.gov.au/publications/illicit-drug-data-report/illicit-drug-data-report-2009-10 (accessed 5 January 2011; archived by WebCite® at http://www.webcitation.org/6CGKv6wqb).
41. Postigo C., López de Alda M. J., Barceló D. Drugs of abuse and their metabolites in the Ebro River basin: occurrence in sewage and surface water, sewage treatment plants removal efficiency, and collective drug usage estimation. Environ Int 2010; 36: 75-84.
42. Australian Crime Commission (ACC). Illicit Drug Data Report 2008-09. Canberra: ACC, 2010. Available at http://www.crimecommission.gov.au/publications/illicit-drug-data-report/illicit-drug-data-report-2008-09 (accessed 15 March 2011; archived by WebCite® at http://www.webcitation.org/6CGLMkdoP).
43. Sindicich N., Burns L. Australian trends in ecstasy and related drug markets 2010: findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trend Series No 46, Sydney, National Drug and Alcohol Research Centre, University of New South Wales. 2010.
44. Sindicich N., Burns L. Australian trends in ecstasy and related drug markets 2010: findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trend Series No 64, Sydney, National Drug and Alcohol Research Centre, University of New South Wales. 2011.
45. Ramaekers J. G., Berghaus G., van Laar M., Drummerd O. H. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 2004; 73: 109-119.
46. Robbe H. W. J. Influence of Marijuana on Driving. University of Limburg, Maastricht, The Netherlands; 1994.
47. Killen P. R. An alternative to null-hypothesis significance tests. Psychol Sci 2005; 16: 345-353.
48. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Hillsdale, NJ: L. Erlbaum Associates; 1988.
49. Hickey S., McIlwraith F., Alati R. Queensland trends in ecstasy and related drug markets 2010. Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Queensland alcohol and drug research and education centre. Australian Drug Trends Series No. 72. 2011.
50. Degenhardt L., Bruno R., Topp L. Is ecstasy a drug of dependence? Drug Alcohol Depend 2010; 107: 1-10.
51. Elliott L., Morrison A., Ditton J., Farrall S., Short E., Cowan L. etal. Alcohol, drug use and sexual behaviour of young adults on a mediterranean dance holiday. Addict Res 1998; 6: 319-340.
52. Australian Bureau of Statistics (ABS). Socio-Economic Indexes for Areas (SEIFA)-Technical Paper. ABS Catalogue no. 2039.0.55.001. Canberra: ABS. 2006.